DJ Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ advanced 2.32% to $491.34 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.05% to 7,354.02 and Dow Jones Industrial Average falling 0.09% to 51,876.11.
This was the stock's fifth consecutive day of gains.
Vertex Pharmaceuticals Inc. closed 3.26% short of its 52-week high of $507.92, which the company achieved on March 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ rose 4.20% to $253.35, Krystal Biotech Inc. (KRYS) rose 3.42% to $372.25, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 0.88% to $6.88.
Data source: Dow Jones Market Data, FactSet. Data compiled June 26, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 26, 2026 16:37 ET (20:37 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.